SciELO - Scientific Electronic Library Online

 
vol.76 suppl.2Acute coronary ischemc syndrome without st elevation: Role of glycoprotein IIb/IIIa inhibitors and percutaneous coronary interventionsRecents considerations of cardiogenic shock associated to the acute coronary ischemic syndromes author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Archivos de cardiología de México

On-line version ISSN 1665-1731Print version ISSN 1405-9940

Abstract

JUAREZ HERRERA, Úrsulo. ST elevation acute coronary syndromes: Pharmaco-mechanic strategy is the universal treatment future?. Arch. Cardiol. Méx. [online]. 2006, vol.76, suppl.2, pp.252-257. ISSN 1665-1731.

The main objective in the medical treatment of the ST elevation acute myocardial infarction, must have the intention to reperfuse the culprit involved artery. In order to reduce this time, the pharmaco-invasive strategy may offer rapid flow recanalization in the culprit artery and reduce the damage of the myocardium. The new pharmacologic combinations includes half dose of fibrinolytics, alone or in combination with llb/llla inhibitors, this combination may offer advantages of the flow. This concept involves the that PCI (Percutaneous Coronary Interventions), can be done in a subsequent time. The risk of bleeding is increased with this strategy, and some evaluation or bleeding risk must be done in all patients, as in patients with 75 years and older.

Keywords : Acute coronary syndromes; Pharmaco-mechanic strategy; Acute myocardial infarction.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License